ubrogepant
Drug Details
- Generic Name
- ubrogepant
- Brand Names
- UBRELVY
- Application Number
- NDA211765
- Sponsor
- Ubrogepant
- NDC Codes
- 5
- Dosage Forms
- POWDER, TABLET
- Routes
- ORAL
- Active Ingredients
- UBROGEPANT
Indications and Usage
1 INDICATIONS AND USAGE UBRELVY is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use UBRELVY is not indicated for the preventive treatment of migraine. UBRELVY is a calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura in adults. ( 1 ) Limitations of Use UBRELVY is not indicated for the preventive treatment of migraine. ( 1 )